Hydroxychloroquine sulfate (“Plaquenil”) in treatment of rheumatoid arthritis

Authors:
  • EHE. B. D. Hamilton
    E. B. D. Hamilton
  • JSJ. T. Scott
    J. T. Scott

Abstract
A controlled therapeutic trial in 41 patients comparing hydroxychloroquine (Plaquenil) and a placebo tablet showed a small but statistically significant difference in favor of hydroxychloroquine with regard to the number of analgesic tablets which the patients found it necessary to take in addition to the drug. Less significant differences, but still in favor of hydroxychloroquine, were found with various other methods of assessment. No serious toxic effects were encountered.

This publication has 15 references indexed in Scilit: